Primary Care Physicians’ Support of Shared Decision Making for Different Cancer Screening Decisions by Lafata, Jennifer Elston et al.
Primary Care Physicians’ Support of Shared Decision Making for 
Different Cancer Screening Decisions
Jennifer Elston Lafata, PhD1, Richard F. Brown, PhD1, Michael P. Pignone, MD2, Scott 
Ratliff, MS3, and L. Aubree Shay, PhD4
1Massey Cancer Center and Department of Health Behavior and Policy, Virginia Commonwealth 
University, Richmond VA
2Division of General Medicine and UNC Institute for Healthcare Quality Improvement, School of 
Medicine, University of North Carolina, Chapel Hill, NC
3Family Medicine and Population Health, Virginia Commonwealth University, Richmond VA
4Department of Health Promotion and Behavioral Sciences, University of Texas School of Public 
Health, San Antonio, TX
Abstract
Background—Despite widespread advocacy, shared decision making (SDM) is not routinely 
used for cancer screening. To better understand implementation barriers, we describe primary care 
physicians’ (PCPs’) support for SDM across diverse cancer screening contexts.
Methods—Mailed survey administered to random sample of US-based PCPs. Using 
multivariable logistic regression we tested association of PCPs’ SDM support with US Preventive 
Service Task Force (USPSTF) assigned recommendation grade, whether decision pertained to not 
screening elders, and PCP’s autonomous vs. controlled motivation-orientation for using SDM.
Results—PCPs (N=278) were on average aged 52 years, 38% female, and 69% white. 79% 
endorsed discussing screening benefits as very important to SDM, compared to 64% for discussing 
risks and 31% for agreeing with patient’s opinion. PCPs were most likely to rate SDM as very 
important for colorectal cancer (CRC) screening in adults aged 50–75 years (69%), and least likely 
for CRC screening in adults aged >85 years (34%). Regression results indicated importance of 
PCPs’ having autonomous or self-determined reasons for engaging in SDM (e.g., believing in 
benefits of SDM) (OR=2.29, 95% CI 1.87, 2.79). PCPs’ support for SDM varied by USPSTF 
recommendation grade (overall contrast, chi-square=14.7, p=0.0054), with support greatest for A-
grade recommendations. Support for SDM was lower in contexts where decision pertained to not 
screening elders (OR=0.45, 95% CI 0.35, 0.56).
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Limitations—Unknown whether PCP’s perception of importance of SDM behaviors differed by 
specific screening decision and potential limited ability to generalize findings.
Conclusions—Results highlight need to document SDM benefits and consider specific 
contextual challenges, such as the level of uncertainty or whether evidence supports 
recommending/not recommending screening, when implementing SDM across an array of cancer 
screening contexts.
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Introduction
The implementation of shared decision making (SDM) in practice—particularly in the 
context of cancer screening—remains suboptimal (1–5). Clinician reported challenges to 
SDM include time constraints, and a perceived lack of applicability due to the clinical 
situation, patient characteristics, or both (6). The US Preventive Services Task Force 
(USPSTF) and the American Cancer Society (7, 8), while consistently advocating that 
clinicians use SDM when discussing cancer screening with their patients, also acknowledge 
the added importance of SDM when individual characteristics and personal preferences are 
central to determining the value of screening to an individual patient. Furthermore, as of 
February 2015, Medicare (for the first time) has mandated the use of SDM for coverage of 
lung cancer screening with low dose computed tomography (9). To our knowledge no prior 
study has considered how such external pressures for SDM, or specific clinical or patient 
contexts, impact physician support for SDM in the context of cancer screening.
In the context of cancer screening, not only are the benefits of SDM underexplored 
empirically (10), but differing levels of uncertainty regarding the balance of benefits and 
risks from screening exist across clinical contexts. This uncertainty is reflected in the 
recommendation grades assigned to different screening by the USPSTF. After reviewing the 
strength of peer-reviewed evidence, and the balance of expected benefits and risks, the 
USPSTF makes a recommendation—often specific to age-and gender-defined population 
subgroups—as “A” (strongly recommends), “B” (recommends), “C” (recommendation 
depends on individual patient), “D” (recommends against), or “I” (insufficient evidence to 
recommend for or against) (11). While there has been varied support for some of the 
USPSTF recommendations (most notably the C recommendation for screening 
mammography before the age of 50 (12)), USPSTF recommendations often serve as the 
basis for performance reporting metrics and prevention-oriented prompts and reminders. Yet, 
variability and uncertainty in the evidence base underlying USPSTF recommendations 
reflect not only the inherent diversity of cancer screening decisions faced in primary care, 
but also the complexities of those decisions as patients and clinicians are expected to 
consider benefit/risk tradeoffs, and individual risk factors, values, and preferences.
As Lègarè and colleagues have speculated, clinician-reported barriers to SDM suggest health 
professionals may decide a priori in which patients or situations to use SDM (6). This may 
be particularly true in the case of older patients where both patients and clinicians perceive 
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barriers to elder participation in decision making (13, 14). In the context of cancer screening, 
the use of SDM among elders may be perceived as additionally challenging as the decision 
faced is often not to initiate or continue with regular screenings, but instead to discontinue 
screenings as health and life expectancy decline. Whether PCPs embrace the use of SDM in 
such scenarios is not known.
Further complicating the adoption of SDM may be a lack of understanding regarding what 
constitutes SDM (15). As conceptualized by the USPSTF, SDM is a process in which all 
patients, regardless of the cancer screening decision, are involved as active partners with 
their clinician to clarify acceptable medical options and decide upon a preferred clinical 
course (8). Yet, evidence exists that physicians may confuse SDM with counseling 
techniques such as motivational interviewing, action plans, or other means to encourage 
patients and their families to accept a clinician’s recommended course of action (16, 17). In 
fact, no singular, agreed upon definition of SDM exists (18, 19), and despite attempts at 
consensus, not even academic experts can agree on the core competencies needed to 
implement SDM (20).
Identifying the factors that alter physician’s support for SDM across the spectrum of cancer 
screening scenarios faced in primary care is important to supporting its implementation, 
particularly as the inherent complexities of such decisions are likely to increase with the 
expansion of genomics and personalized medicine. In this paper we (1) describe PCPs’ 
beliefs regarding the importance of different communication behaviors to SDM, (2) report 
PCPs’ support for using SDM across 11 specific cancer screening contexts, and (3) test 
whether that support varies by physician characteristics, including their belief in the inherent 
benefit of SDM (vs. external pressure to use SDM), and characteristics of the clinical 
context, as characterized by the USPSTF recommendation grade, and patient context, as 
characterized by whether the decision is specific to not screening elder patients. Given 
known time constraints in primary care, particularly in relation to preventive service delivery 
(21), we anticipated that PCPs may be relatively more inclined to endorse the importance of 
SDM when, because of either uncertainties or similarities in the expected magnitude of 
benefits and risk, decisions are likely sensitive to individual patient preferences (i.e., grades 
“C” and “I”) in comparison to those screening contexts where the potential for benefits or 
risks dominated (i.e., grades “A” and “D”).
Methods
Physician Sample and Survey Administration
The target study population was office-based PCPs practicing in the United States. In 
January 2015, an authorized vendor of the American Medical Association’s (AMA’s) 
Physicians Masterfile (22) identified a random sample of family medicine, general internal 
medicine, and general practice physicians aged 75 years or younger. Using that sample, we 
administered a mailed survey to N=1,430 PCPs between February and May 2015 (a time 
period that coincided with Medicare’s initiation of coverage for lung cancer screening, but 
preceded Medicare’s formal announcement of that coverage).
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Survey administration followed a modified Dillman approach (23). We initially sent a letter 
of study introduction. Two weeks later, we mailed a survey packet that included a cover 
letter, survey booklet, pre-stamped return envelope, and a $2 bill. Two weeks after that 
mailing we sent a reminder postcard to those who had yet to return the survey. Two weeks 
following the postcard reminder, we sent non-responders a second survey packet. Those who 
completed the survey received a $10 gift card. We sent all correspondence via US Postal 
Service, using first class postage stamps and personalized salutations. The Institutional 
Review Board of the Virginia Commonwealth University approved all aspects of the study.
Survey Content and Analytical Variables
Using a 4-point Likert response scale (i.e., not at all important, minimally important, 
somewhat important and very important), the survey collected information regarding 
respondents’ support for the importance of SDM in the context of 11 specific cancer 
screening decisions (Table 1). Four of these contexts (e.g., mammography screening among 
women ≥75 years, cervical cancer screening in previously screened women >65 years, 
colorectal cancer screening in adults aged 75–85, and colorectal screening in adults >85 
years) pertain to recommendations not to screen elders, and therefore likely to a decision to 
discontinue or not screen an individual who has previously engaged in screening.
The survey used the same 4-point Likert response scale to obtain respondents’ beliefs 
regarding the importance of 11 communication behaviors to SDM. Behaviors assessed were 
adapted from those described by Makoul and Clayman (18) and included: (1) presenting 
screening as a choice, (2) discussing testing benefits, (3) discussing testing risks, (4) eliciting 
patient information preferences, (5) discussing patient barriers to screening, (6) making a 
screening recommendation, (7) checking patient understanding of screening advantages/
disadvantages, (8) discussing “next steps,” (9) eliciting patient preference for decision-
making involvement, (10) checking to see if screening is agreeable to patient, and (11) 
encouraging question asking.
The PCP’s underlying motivation for using SDM was assessed using 10 items from the 
Treatment Self-Regulation Questionnaire (TSRQ) (24). First introduced by Ryan and 
Connell (25), these questions use 7-point Likert response scales to ascertain how true (i.e., 
not at all true to very true) a list of reasons is for why the respondent would engage in or 
change a behavior. The TSRQ includes six autonomous or self-determined reasons (e.g., I 
would use shared decision making with my patients because: “I personally believe it is the 
best thing for my patients’ health” or “It is important for being as good a doctor as 
possible”) and four controlled or externally-regulated reasons (e.g., I would use shared 
decision making with my patients because: “Others would be upset with me if I did not” or 
“I feel pressure from others to do so.”). The TSRQ has been validated across a variety of 
health behaviors and populations (26), but to our knowledge has not previously been used to 
understand physician behavior. As is typically done with the TSRQ, we constructed two 
variables that ranged from 1–7. The first represented the average of responses to the 6 
autonomous-oriented questions, and the second represented the average of responses to the 
four controlled-oriented questions.
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The survey also ascertained physician characteristics including age, gender, race, and 
practice size. Information on physician specialty (i.e., general internal medicine, family 
medicine) and medical school affiliation were ascertained from the AMA Physician 
Masterfile.
Statistical Methods
We report the percent of PCPs who endorsed each communication behavior by the level of 
importance endorsed. We also report the percent who endorsed SDM by the level of 
importance endorsed for each of the specific cancer screening contexts. Prior to conducting 
multivariable analyses, we collapsed Likert scale responses to “very important” vs. other 
based on the overall lack of variability across responses. To evaluate the physician and 
screening-context factors associated with PCPs’ support for SDM, we fit multivariable 
logistic regression models with up to 11 repeated observations per physician (i.e., one for 
each of the 11 specific cancer screening decisions). This was done using generalized 
estimating equations (GEE) with the PROC GENMOD procedure with REPEATED 
statements in SAS (27). To test the hypothesis that a physician’s likelihood of supporting 
SDM varied by USPSTF recommendation grade, we tested an overall contrast (using the 
type 3 analysis of effect chi-square available in SAS), and then, if the overall contrast was 
significant (p<0.05), tested for specific pairwise differences between recommendation 
grades. We also included a variable reflective of whether or not the screening decision 
pertained to discontinuing routine screening among elders. Finally, the model controlled for 
physician-level factors including age, gender, race, specialty, medical school/university 
affiliation, practice size and the PCP’s autonomous and controlled regulation for using 
SDM.
Results
Sample Characteristics
Of the 1430 PCPs who were mailed a survey, 307 were returned, of which 278 were eligible 
(i.e., PCP with active office-based practice). After adjusting for ineligible cases, the survey 
response rate was 24% (28). Among those sent a survey, we compared responders and non-
responders in terms of age, gender, specialty, university affiliation, and practice region. We 
found no statistically significant differences with the exception of specialty: Those who 
responded to the survey were more likely to be family medicine physicians when compared 
to non-responders (i.e., 58% vs. 49%).
On average, sample PCPs were 51.9 years of age (sd 10.8). Sixty-nine percent were white 
(69%) and 38% were female. The sample was equally distributed across solo/partner 
practices (33%), small practices (3–10 physicians, 37%) and large practices (11 or more 
physicians, 31%), and 35% were affiliated with a medical school. The mean PCP motivation 
for using SDM because of its inherent benefits was 6.0 (range=2.3–7.0) while the mean PCP 
motivation for using SDM due to external pressures was substantively lower at 2.6 
(range=1.0–7.0).
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Physician Beliefs about Shared Decision Making Behaviors
Primary care physicians varied in their beliefs regarding the importance of different 
communication behaviors to SDM (Table 2). For example, while 79% endorsed discussing 
the benefits of tests as very important to SDM, this dropped to 64% for discussing the risks 
associated with tests. Similarly, while 77% endorsed encouraging patients to ask questions 
as very important to SDM, this dropped to 67% for presenting screening as a choice. Fewer 
endorsed eliciting the patient’s preferences for information (53%).
Physician Support for Shared Decision Making
When asked about the importance of SDM for cancer screening in general, 77% of 
respondents indicated that SDM was very important. However, when asked about the 
importance of SDM for specific cancer screening contexts, substantively fewer endorsed 
SDM as very important (Table 3). At the high end, 69% of PCPs supported SDM as very 
important for colorectal cancer screening among adults aged 50–75 years. At the other 
extreme, less than half supported SDM as very important in the context of mammography 
screening in women aged 75 years or older (44%), cervical cancer screening in previously 
screened women over the age of 65 years (42%), colorectal cancer screening among adults 
aged 75–85 years (40%) and colorectal cancer screening among adults over age 85 years 
(34%). With the exception of the four scenarios that pertain to cancer screening among the 
aged (i.e., mammography screening among women aged 75 and older [21.8%], cervical 
cancer screening among women aged 65 and older [27.4%], colorectal cancer screening 
among individuals aged 75–85 years [30.6%], and colorectal cancer screening among 
individuals aged 85 and older [48.6%]), PCPs rarely (<15%) endorsed SDM as either not at 
all important or minimally important.
As evidenced by the size of the intra-class correlation coefficient (ICC = 0.33) from the 
logistic regression model (Table 4), PCPs had a tendency to be either more or less supportive 
of SDM, regardless of clinical or patient context. However, among the physician 
characteristics included in the model, none were significant except the PCP’s motivation for 
using SDM: The more PCPs indicated they engaged in SDM because of their belief in the 
inherent benefits of SDM (i.e., the more they endorsed autonomous or self-determined 
regulation reasons for engaging in SDM) the more likely they were to support using SDM: 
for every one-point increase in a PCP’s average response on the 7-point Likert scale, he or 
she was over twice as likely to support SDM as very important (Table 4).
Results from the adjusted logistic regression model further indicated that PCPs’ likelihood 
of supporting SDM varied by USPSTF recommendation grade (type 3 analysis of effect chi-
square=14.7, p=0.0054). Specifically, PCPs were significantly more likely to support SDM 
among USPSTF grade A (“Strongly recommends”) screening contexts compared to those 
contexts with other recommendation grades (Table 4). We also tested for each of the other 
pairwise comparisons, finding only the difference between USPSTF-grade C recommended 
services in comparison to grade D recommended services (OR=1.19, 95% CI 1.00, 1.42) 
statistically significant (results not shown). In addition, physicians’ support for using SDM 
was half as likely when the screening decision pertained to not screening elder patients 
(Table 4).
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Discussion
Our results point to variation in PCPs’ support for SDM across the diverse cancer screening 
contexts typically faced in primary care and variation in PCPs’ understanding of the 
behaviors important to SDM. In addition to their beliefs regarding the inherent benefits of 
SDM, variation in PCPs’ support for SDM stems from specific characteristics of the 
screening contexts, such as the evidence base underlying the screening decision and whether 
or not the decision pertains to not screening elders.
While it may be unrealistic to expect PCPs to use SDM for the delivery of all cancer 
screening, a priori, if PCPs were using SDM as commonly advocated, it seems reasonable to 
expect PCPs to endorse the importance of SDM when there is a high degree of uncertainty 
or when the expected balance of benefits and risks is similar and thus, when decisions are 
likely sensitive to individual patient preferences (i.e., recommendation grades “C” and “I”). 
Instead, we found that PCPs were more likely to support the importance of SDM when there 
was a strong and certain evidence-base that the benefits of screening outweighed the 
potential risks (i.e., for those screening decisions with a USPSTF A-grade recommendation). 
This finding arguably makes sense in the context of colorectal cancer screening among 
adults aged 50–75 years—a screening context with an A-grade recommendation where 
deciding among multiple available screening tests is considered a preference sensitive 
choice. However, given that studies repeatedly have shown that physicians infrequently offer 
patients a choice among available colorectal cancer screening tests, instead defaulting to one 
of the available options (29, 30), PCPs’ support of SDM in this context also may be due to 
other factors. For example, support for SDM in the context of an A-grade recommendation 
is consistent with the prior finding that physicians describe SDM as a process in which they 
try to convince patients to agree to a physician preferred clinical course of action (16). 
Others have suggested that physicians may feel a tension between a desire to engage patients 
and consider their preferences, and the need to adhere to evidence-based practice guidelines 
(31, 32).
We found consistently less PCP support for SDM in screening contexts where the decision 
was to discontinue screening among elders rather than to initiate or continue routine 
screening. It may be that time pressures in combination with pressures to adhere to 
evidence-based guidelines leave PCPs with little opportunity to raise these screening options 
with patients. It may also be that such conversations are uncomfortable for PCPs. Others 
have found that physicians are more likely to discuss tests with patients if they “believe in 
the test and intend to order it” (2). Regardless of the reason, the consistent void in support 
for the importance of SDM in these contexts is troubling, as it may, on one hand, lead 
healthy older adults to not receive appropriate screening, while on the hand lead to 
unnecessary screening among those with limited life expectancy.
We found that physician beliefs regarding the inherent benefits of SDM, and not external 
pressure to use SDM, are associated with PCPs’ endorsement of the importance of SDM 
across diverse cancer screening contexts. A recent systematic review found surprising few 
evaluations of the relationship between SDM and patient outcomes in which both the 
decision-making process and patient outcome were empirically measured (10). That same 
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review found that affective-cognitive outcomes, and not behavioral and health outcomes, 
were both most often studied and found to be impacted by SMD (10). Thus, while there are 
strong ethical and interpersonal reasons to advocate for SDM, external pressure for 
clinicians to use SDM may fall upon deaf ears until the outcome benefits of SDM are better 
understood.
In the context of cancer screening demonstrating these benefits may be especially important: 
PCPs are likely to feel pressure to adhere to frequently monitored evidence-based screening 
recommendations and patients rarely consider the risks associated with routine screening 
(33, 34). Of particular note are our findings regarding PCPs’ support for SDM in the context 
of lung cancer screening—a context for which SDM is now required by Medicare for 
reimbursement (9). Despite Medicare’s tying reimbursement to documented use of SDM, we 
found barely half of PCPs indicated SDM was very important in the context of lung cancer 
screening. It is important to note, however, that our survey was in the field in the four 
months immediately following the CMS coverage announcement, and thus PCPs’ beliefs 
may be shifting with time. Nonetheless, such findings suggest that additional training and 
education of providers likely is necessary to fully realize the benefits of SDM for lung 
cancer screening, a service with many potential benefits but also clear uncertainties and 
risks.
In addition to variable support for SDM across cancer screening contexts, we also found 
variable beliefs regarding the importance of many of the behaviors endorsed as central to 
SDM. While this lack of endorsement alone is of note, the patterns observed are also worthy 
of consideration. Clinicians were more likely to endorse the discussion of benefits as very 
important to SDM than they were to endorse a discussion of risks as very important. 
Likewise, they were less inclined to endorse checking that patients understand advantages 
and disadvantages as very important, than they were to support making a recommendation. 
Such findings are consistent with the idea that PCPs may view SDM as a tool to help 
convince patients to adhere to guideline recommended cancer screening and thus as having 
little value when screening is not recommended. Whether PCPs’ beliefs regarding the 
importance of these communication behaviors may vary across different cancer screening 
contexts deserves further exploration.
Our results illustrate not only the need for education and training in SDM, but also the need 
for clinical and patient context to be considered within that education and training. For the 
inherent complexities present in cancer screening decisions to be considered more fully, 
PCPs need to be willing and able to engage in SDM with their patients across a diversity of 
cancer screening contexts. These contexts include not only those where patient preferences 
should play a role in deciding among options of equal clinical effectiveness, but also those 
where the benefit/risk profile changes as patients age, or where net benefit is low or unclear, 
and where risks are well known. Given patients often want to seek guidance from their 
physicians when deciding about cancer screening (35) and the ongoing challenges of 
incorporating traditional decision aids into clinical practice (36), additional research is 
needed to identify innovative tools and techniques to support what are increasingly complex 
cancer screening decisions.
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We studied only established SMD behaviors, or those experts in the field of SDM consider 
important to SDM. There may be other behaviors that PCPs think are important to SDM. 
Furthermore, we did not collect information about and therefore cannot test whether PCPs’ 
beliefs regarding the importance of different SDM behaviors varies across specific cancer 
screening contexts or whether some of their reported support for SDM within a given 
screening context is confounded by their agreement (or disagreement) with the 
recommendation grade assigned by the USPSTF. In addition, our survey response rate, while 
comparable to other physician surveys (37), and reflective of well-documented declining 
PCP responses to mailed surveys (37), raises caution when generalizing findings beyond the 
current sample.
Contrary to our expectations that time and other constraints might lead PCPs to endorse the 
importance of SDM relatively more when uncertainties exist or when the balance of benefits 
and risks are similar, and thus when decisions are sensitive to individual patient preferences, 
we found PCPs most likely to endorse the importance of SDM when evidence of the benefits 
outweighed the risks with a high level of certainty. One plausible explanation for this 
finding, which is consistent with the findings of others (16, 17), is that PCPs may equate 
SDM with counseling strategies that are primarily used to convince patients to adhere to 
guideline recommended cancer screening. As such, our findings support ongoing concerns 
that the inherent complexities of cancer screening decisions are not being addressed in 
practice (2, 38). For SDM to be more widely implemented, PCPs need to be able to 
understand the benefits of SDM and what specific communication behaviors contribute to 
those benefits. Furthermore, educational and other efforts need to help integrate the use of 
SDM across diverse cancer screening contexts, including those in which evidence for 
screening use is weak or ambiguous.
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Table 1
US Preventive Services Task Force–Assigned Recommendation Grade and Practice Suggestion by Cancer 
Screening Decision
Screening Decision Recommendation Grade Practice Suggestion
• Cervical cancer screening in women aged 21–65 years
• Colorectal cancer screening in adults aged 50–75 years
A High certainty net benefit is substantial. Offer or provide service
• Lung cancer screening in adults aged 55–80 years, who 
smoke or recently quit
• Screening mammography in women aged 50–74 years
B High certainty net benefit is moderate or 
moderate certainty net benefit is moderate to 
substantial.
Offer or provide service
• Screening mammography in women before the age of 
50
• Colorectal cancer screening in adults aged 75–85 years
C At least moderate certainty net benefit is 
small.
Offer/provide for selected 
patients depending on 
individual circumstances
• Cervical cancer screening in previously screened, 
average risk women >65 years
• PSA in average risk men
• Colorectal cancer screening in adults >85 years
D Moderate or high certainty that the service 
has no benefit or that the risks outweigh the 
benefits.
Discourage use
• Mammography in women >=75 years
• Skin exam for cutaneous melanoma, basal cell cancer, 
or squamous cell skin cancer
I Insufficient evidence to assess benefit/risk 
balance. Evidence lacking, poor quality, or 
conflicting.
If offered, patients should 
understand uncertainty 
regarding balance of benefits/
risks
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Table 2
Primary Care Physicians’ Beliefs Regarding Shared Decision Making Behaviors
Shared Decision Making Behavior Very Important
Discussing benefits of cancer screening tests 79%
Encouraging patient to ask questions 77%
Making a recommendation about screening 73%
Checking with patient to see if screening is agreeable 68%
Presenting screening as a choice 67%
Discuss the risks associated with screening tests 64%
Discussing “next steps” with the patient 61%
Eliciting patient’s preference for involvement in decision 61%
Check patient’s understanding of advantages/disadvantages of screening 60%
Discussing patient’s barriers to cancer screening 58%
Eliciting patient preferences for information 53%
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Table 3
Primary Care Physicians’ Support for Shared Decision Making by Cancer Screening Decision
Evidence Grade Cancer Screening Context Very Important
A Colorectal cancer screening in adults 50–75 years 69%
A Cervical cancer screening in women 21–65 years 61%
B Screening mammography in women 50–74 years 60%
C Mammography in women before the age 50 60%
B Lung cancer screening in adults 55–80 years 58%
D Prostate-specific antigen in average risk men 57%
I Skin exam for cutaneous melanoma, basal cell cancer, or squamous cell skin cancer 56%
I Mammography in women >=75 years 44%
D Cervical cancer screening in previously screened women >65 years 42%
C Colorectal cancer screening in adults 75–85 years 40%
D Colorectal cancer screening in adults >85 years 34%
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Table 4
Factors Associated with Physicians’ Support for Shared Decision Making: Adjusted Logistic Regression 
Results1
Odds Ratio 95% CI
Screening Context
USPSTF Evidence Grade
A 1.00
B 0.74 0.61, 0.91
C 0.76 0.58, 0.99
D 0.63 0.48, 0.83
I 0.72 0.57, 0.91
Decision not to screen elders 0.45 0.36, 0.56
Physician
Age 0.99 0.98, 1.01
Race
White 1.00
Asian 1.05 0.67, 1.64
Other 0.85 0.52, 1.39
Male 1.00
Female 1.27 0.90, 1.77
Specialty
Family medicine 1.00
General internal medicine/other 1.02 0.74,1.39
No university affiliation 1.00
University affiliation 0.92 0.67, 1.27
Motivation for shared decision making (SDM)
Benefits of SDM (intrinsic) 2.29 1.87, 2.79
External pressure (extrinsic) 0.94 0.84, 1.05
Practice size
Solo/partner 1.00
Small group 0.87 0.59, 1.29
Large group 0.88 0.59, 1.33
1
Interclass correlation coefficient = 0.33.
USPSTF, United States Preventive Services Task Force.
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